Hrt Financial LP Vaxart, Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.56 - $1.41 $290,958 - $732,592	519,569 Added 5191.02%	529,578 $688,000
Q4 2023 Feb 09, 2024	BUY	$0.57 - $0.85 $5,705 - $8,507	10,009 New	10,009 $5,000
Q2 2023 Aug 11, 2023	BUY	$0.6 - $1.41 $72,500 - $170,375	120,834 New	120,834 $88,000
Q4 2022 Feb 10, 2023	BUY	$0.75 - $2.24 $408,179 - $1.22 Million	544,239 New	544,239 $522,000
Q2 2022 Aug 12, 2022	BUY	$2.7 - $5.28 $230,971 - $451,677	85,545 New	85,545 $299,000

108

40.6M

96.7K

239K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $108M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.